TGFB2 and glioblastoma: High TGFB2 mRNA level was a poor prognostic indicator for DIPG patients but not for DMG patients whose tumors were outside of the pons/brainstem in locations such as the cerebellum and thalamus or pediatric glioblastoma (GBM) patients.